Recursion Pharmaceuticals is a next-gen biopharma company combining experimental biology and automation with artificial intelligence to discover potential drugs for genetic disease, inflammation, immunology, and infectious disease.
Recursion's IPO Generates $502 Million, Mark Tullis, April 2021
Recursion Announces Partnerships with Roche and Genentech, December 10, 2021
Recursion Pharmaceuticals Files for a $100 Million IPO, March 26th, 2021
Our mission is to shine a spotlight on the many great things happening in the Utah technology and startup community, and to be a fair, independent voice for the Utah Tech Scene.
All contents © 2022 IsoTalent Inc. All rights reserved.
TechBuzz is an IsoTalent company
Newsletter - Sign up to receive TechBuzz News weekly